Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Today, a vast majority of Ireland’s corporate tax revenue comes from multinational drug companies and tech giants, which have also used Ireland to shift profits.
Simplified Text
A vast majority of Ireland’s corporate tax revenue comes from multinational drug companies and tech giants.
Confidence Score
0.900
Claim Maker
The author
Context Type
News Article
Context Details
{
    "industry": "Pharmaceutical, Tech",
    "location": "Ireland"
}
Subject Tags
UUID
9fdb5dc6-32ed-4bd3-a1c4-2f8efa0f1084
Vector Index
✗ No vector
Created
September 12, 2025 at 2:46 AM (2 days ago)
Last Updated
September 12, 2025 at 2:46 AM (2 days ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html?campaign_id=9&emc=edit_nn_20250815&instance_id=160603&nl=the-morning&regi_id=122976029&segment_id=203954&user_id=b25c5730c89e0c73f75709d8f1254337
https://www.nytimes.com/2025/08/14/health/pharma-tariffs-ireland-taxes.html?campaign_id=9&emc=edit_nn_20250815&instance_id=160603&nl=the-morning&regi_id=122976029&segment_id=203954&user_id=b25c5730c89e0c73f75709d8f1254337

US drugmakers using Ireland for tax advantages face billions in tariffs from planned 15% levy on European medicines. Companies may shift production to the US, incurring increased costs.

Pharmaceutical Industry
International Trade
Taxation
Ireland
United States
Tariffs
Corporate Tax Avoidance

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP